Colleran David

Colleran David is listed in filings as EVP at Anika Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 17, 2026, including 13 public disclosures. Recent filings connect the profile to Anika Therapeutics, Inc. (ANIK). The current snapshot covers public activity from Mar 11, 2025 to Mar 17, 2026. Reported amounts are shown as $26.9K to $30.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.